Patients Views & Analysis

Views & Analysis

3 steps for comprehensive patient collaboration

Janssen’s Daniel de Schryver tells us why it’s time to give patients a permanent seat at the table and improve health outcomes through patient-pharma dialogue.

Views & Analysis

Bridging the gap between pharma and the NHS in MS

Janette Curlis is a Multiple Sclerosis Nurse Advisor (MSNA) at Biogen, helping to support the company’s Multiple Sclerosis (MS) field teams and developing patient and Healthcare Professiona

Oncology

Turning patient engagment to patient centricity

Being part of the conversation: Turning patient engagement t...

After three brushes with cancer, Robert Weker understands the patient journey more than many – and he is determined to put that experience to good use.

Views & Analysis

Ring 20: Could the rare disease get left behind by next-gene...

Ring Chromosome 20 Syndrome, or (R)20, is an ultra-rare form of epilepsy with a devastating impact – yet despite huge leaps forward in gene sequencing in recent years, diagnoses are going d

Views & Analysis

Why 72% of patients don’t feel listened to by pharma

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like.

Patients